Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders

被引:0
|
作者
I. M. Carvalho
P. B. Coelho
P. C. Costa
C. S. Marques
R. S. Oliveira
D. C. Ferreira
机构
[1] University of Porto,Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy
[2] University Fernando Pessoa,Department of Pharmaceutical Technology, Faculty of Health Sciences
来源
NeuroMolecular Medicine | 2015年 / 17卷
关键词
Neurogenesis; Neurotrophic factors; Neural stem cells; Neurodegenerative disorders; Retinoic acid; Curcuminoids;
D O I
暂无
中图分类号
学科分类号
摘要
The adult central nervous system is commonly known to have a very limited regenerative capacity. The presence of functional stem cells in the brain can therefore be seen as a paradox, since in other organs these are known to counterbalance cell loss derived from pathological conditions. This fact has therefore raised the possibility to stimulate neural stem cell differentiation and proliferation or survival by either stem cell replacement therapy or direct administration of neurotrophic factors or other proneurogenic molecules, which in turn has also originated regenerative medicine for the treatment of otherwise incurable neurodegenerative and neuropsychiatric disorders that take a huge toll on society. This may be facilitated by the fact that many of these disorders converge on similar pathophysiological pathways: excitotoxicity, oxidative stress, neuroinflammation, mitochondrial failure, excessive intracellular calcium and apoptosis. This review will therefore focus on the most promising achievements in promoting neuroprotection and neuroregeneration reported to date.
引用
收藏
页码:404 / 422
页数:18
相关论文
共 50 条
  • [1] Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders
    Carvalho, I. M.
    Coelho, P. B.
    Costa, P. C.
    Marques, C. S.
    Oliveira, R. S.
    Ferreira, D. C.
    NEUROMOLECULAR MEDICINE, 2015, 17 (04) : 404 - 422
  • [2] NCAM in Neuropsychiatric and Neurodegenerative Disorders
    Brennaman, Leann H.
    Maness, Patricia F.
    STRUCTURE AND FUNCTION OF THE NEURAL CELL ADHESION MOLECULE NCAM, 2010, 663 : 299 - 317
  • [3] Current advances in using neurotrophic factors to treat neurodegenerative disorders
    Weissmiller A.M.
    Wu C.
    Translational Neurodegeneration, 1 (1)
  • [4] Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
    Shah, Sweta
    Dooms, Marc Marie
    Amaral-Garcia, Sofia
    Igoillo-Esteve, Mariana
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] Neurosciences I: Neurodegenerative and neuropsychiatric disorders
    Shoulson, I
    Brady, LS
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 105 - 117
  • [6] Putative neuroprotective agents in neuropsychiatric disorders
    Dodd, Seetal
    Maes, Michael
    Anderson, George
    Dean, Olivia M.
    Moylan, Steven
    Berk, Michael
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 42 : 135 - 145
  • [8] Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism
    Lee, Yujeong
    Kim, Min-Sun
    Lee, Jaewon
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (10) : 1117 - 1128
  • [9] Neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism
    Yujeong Lee
    Min-Sun Kim
    Jaewon Lee
    Archives of Pharmacal Research, 2017, 40 : 1117 - 1128
  • [10] Neurogenic regions in the adult: Relationship with the neuropsychiatric disorders
    Ramirez-Rodriguez, Gerardo
    del Carmen Silva-Lucero, Maria
    Gomez-Virgilio, Laura
    del Angel Ocana-Fernandez, Maria
    Ortiz-Lopez, Leonardo
    Torres-Perez, Mario O.
    Antonio Meraz-Rios, Marco
    SALUD MENTAL, 2013, 36 (03) : 201 - 210